KJX839: 7 Clinical Trials

Study of Efficacy and Safety of Inclisiran in Asian Participants With Atherosclerotic Cardiovascular Disease (ASCVD) or ASCVD High Risk and Elevated Low Density Lipoprotein Cholesterol (LDL-C)

Condition(s):HypercholesterolemiaLast Updated:February 21, 2021Not yet recruiting

Study of Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inclisiran in Chinese Participants With Elevated Serum LDL-C

Condition(s):HyperlipidemiaLast Updated:March 30, 2021Recruiting

Study of Efficacy and Safety of Inclisiran in Japanese Participants With High Cardiovascular Risk and Elevated LDL-C

Condition(s):Hypercholesterolemia; Heterozygous Familial HypercholesterolemiaLast Updated:December 14, 2020Not yet recruiting

Study to Evaluate Efficacy and Safety of Inclisiran in Adolescents With Homozygous Familial Hypercholesterolemia

Condition(s):Homozygous Familial HypercholesterolemiaLast Updated:March 30, 2021Recruiting

Study to Evaluate Efficacy and Safety of Inclisiran in Adolescents With Heterozygous Familial Hypercholesterolemia

Condition(s):Heterozygous Familial HypercholesterolemiaLast Updated:March 26, 2021Recruiting

A Study of Inclisiran in Participants With Homozygous Familial Hypercholesterolemia (HoFH)

Condition(s):Homozygous Familial HypercholesterolemiaLast Updated:March 12, 2021Active, not recruiting

Study in Primary Care Evaluating Inclisiran Delivery Implementation + Enhanced Support

Condition(s):Atherosclerotic Cardiovascular Disease; Atherosclerotic Cardiovascular Disease Risk Equivelents; Elevated Low Density Lipoprotein CholesterolLast Updated:March 19, 2021Not yet recruiting

Trial Bulletin .com

Clinical Trials by Category

Clinical Trials Alphabetically

About

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.